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Abstract
Introduction
Body mass index (BMI) and indicators of central adiposity 
have been associated with cardiovascular disease (CVD) 
risk factors, but ambiguity remains about which measure 
optimally predicts CVD risk and is best suited for differ-
ent racial/ethnic groups. We sought to characterize excess 
adiposity  among  New  York  City  adults  and  assess  the 
potential associations between multiple adiposity indica-
tors and CVD risk factors, by race/ethnicity.
Methods
The New York City Health and Nutrition Examination 
Survey  (NYC  HANES)  is  a  population-based  survey 
of  noninstitutionalized  New  York  City  adult  residents 
aged 20 years or older. We compared the prevalence of 
obesity (BMI ≥30 kg/m2), elevated waist circumference 
(>102  cm  for  men,  >88  cm  for  women),  and  elevated 
waist-to-height ratio (≥0.5) for participants in the 2004 
NYC HANES (n = 1,912) and the 2003-2004 National 
Health and Nutrition Examination Survey (n = 4,075). 
Logistic regression was used to assess potential associa-
tions between each of these indicators of excess adiposity 
and CVD risk factors (diabetes, impaired fasting glucose, 
hypertension, and hypercholesterolemia), overall and by 
race/ethnicity.
Results
The  prevalence  of  obesity  among  NYC  HANES  partici-
pants was 26% and of elevated waist circumference was 
46%, both significantly lower than national estimates (31% 
and 52%, respectively), whereas the prevalence of elevated 
waist-to-height ratio was higher (82% vs 79%). Most mea-
sures of excess adiposity were significantly associated with 
all CVD risk factors. No single measure of excess adiposity 
emerged as most consistently predictive of CVD risk in the 
general population or by race/ethnicity.
Conclusion
New  York  City  has  a  lower  prevalence  of  obesity  and 
elevated  waist  circumference  but  a  higher  prevalence 
of  elevated  waist-to-height  ratio  than  found  nationally. 
Further investigation into the optimal adiposity measure 
to predict CVD risk across racial/ethnic populations may 
be warranted.
Introduction
Obesity, a body mass index (BMI) of at least 30 kg/m2, 
is a standard measure of excess adiposity used to assess 
health risk nationally and internationally. The prevalence 
of obesity has risen from 23% to 32% among US adults in 
the past decade (1) and has been linked to increases in car-
diovascular disease (CVD) risk factors (2) as well as death 
rates from CVD and all causes (3).
Although  BMI  is  a  widely  accepted  measure  of  over-
all  body  mass,  some  findings  suggest  that  measures  of   
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central  adiposity  have  stronger  associations  with  CVD. 
Two  Australian  studies  found  that  waist-to-hip  ratio 
was  more  strongly  correlated  with  CVD  risk  than  was 
BMI, waist circumference, or waist-to-height ratio (4,5). 
Alternatively, recent work indicated that waist-to-height 
ratio was more strongly associated with diabetes, hyper-
tension,  and  dyslipidemia  than  were  other  adiposity 
measures (6). Other studies maintain that BMI, or BMI 
in conjunction with measures of central adiposity, predicts 
CVD outcomes as well as or better than central adipos-
ity  measures  (7).  Recent  findings  have  not  consistently 
shown a single indicator to be more highly associated with 
CVD risk, but the relationship is further complicated by 
the varying associations between adiposity measures and 
CVD risk by race/ethnicity (8). Ambiguity remains about 
which adiposity measure optimally predicts CVD risk and 
is best suited for different racial/ethnic groups.
New  York  City  is  a  diverse  urban  community,  with  a 
higher  percentage  of  black,  Hispanic,  and  low-income 
residents — all groups with documented high prevalence 
of obesity — than national averages (1). Although recent 
studies have quantified racial/ethnic disparities in CVD 
risk factors in New York City (9,10), none has assessed the 
racial/ethnic differences in associations between multiple 
adiposity measures and CVD risk factors.
We used data from the 2004 New York City Health and 
Nutrition Examination Survey (NYC HANES) to charac-
terize excess adiposity (obesity, elevated waist circumfer-
ence, and elevated waist-to-height ratio) among New York 
City adults. We then compared local estimates to similarly 
measured  national  estimates  by  using  National  Health 
and Nutrition Examination Survey (NHANES) 2003-2004 
data. We further assessed the association between each 
adiposity measure and CVD risk factors, overall and by 
race/ethnicity.
Methods
NYC HANES is a population-based, cross-sectional survey 
of  noninstitutionalized  New  York  City  adult  residents. 
Modeled after NHANES, the 2004 NYC HANES used a 3-
stage probability design to select a representative sample 
of participants aged 20 years or older. The survey included 
a  physical  examination,  laboratory  testing,  and  a  face-
to-face  and  computer-assisted  self-interview.  A  detailed 
description  of  the  study’s  methods  has  been  published 
elsewhere (11).
All measurements and specimen collection were conducted 
by using standardized protocols and equipment consistent 
with those used for NHANES (12). We excluded pregnant 
women (n = 29) and participants without valid anthropo-
metric values (n = 58), for a final sample of 1,912 partici-
pants. For analyses of diabetes, fasting blood glucose was 
measured from a subsample of participants who fasted for 
8 hours (n = 1,275). A detailed description of the fasting 
sample is provided elsewhere (10).
NHANES is an ongoing population-based, cross-sectional 
survey of noninstitutionalized US residents aged 2 months 
or older (12). Similar to NYC HANES, NHANES uses a 
multistage cluster sampling design. To be consistent with 
NYC  HANES,  we  analyzed  NHANES  2003-2004  data 
for adults aged 20 years or older and excluded pregnant 
women  and  participants  without  valid  anthropometric 
values, for a final sample of 4,075 participants.
Participants with a BMI of at least 30 kg/m2 were classi-
fied as obese (13). We defined elevated waist circumfer-
ence as greater than 102 cm in men and greater than 88 
cm in women (13) to be consistent with cutoffs developed 
by the National Institutes of Health to identify the risk for 
obesity-related health outcomes in overweight and obese 
adults. We defined waist-to-height ratio as waist circum-
ference in centimeters divided by height in centimeters. 
Because  no  established  cutoffs  for  waist-to-height  ratio 
exist, we used a value of 0.5 or more, proposed by Ashwell 
and  Hsieh,  as  being  indicative  of  increased  health  risk 
across sex and race/ethnicity groups (14).
Lipid profiles were analyzed at the Lipoprotein Analytical 
Laboratory at Johns Hopkins University Hospital. Blood 
glucose levels were measured at the University of Missouri 
Diabetes  Diagnostic  Laboratory  according  to  NHANES 
protocols (15).
We defined hypertension as a systolic blood pressure mea-
surement of at least 140 mm Hg or a diastolic blood pres-
sure measurement of at least 90 mm Hg or currently tak-
ing prescribed antihypertensive medications. We defined 
hypercholesterolemia as a total cholesterol measurement 
of at least 240 mg/dL or currently taking prescribed choles-
terol-lowering medications (16). We defined diabetes as a 
fasting plasma glucose measurement of at least 126 mg/dL 
or participant self-report that a health care provider had 
ever told them that they had diabetes (other than during 
pregnancy for women). Impaired fasting glucose (IFG) was 
defined as having a fasting plasma glucose measurement VOLUME 8: NO. 3
MAY 2011
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of 100 to 125 mg/dL among participants who did not self-
report diabetes (17).
Demographic variables were age, sex, race/ethnicity, edu-
cation,  income,  nativity,  smoking,  exercise,  and  alcohol 
use. We defined nativity as US-born or foreign-born (par-
ticipants born in Puerto Rico, US Virgin Islands, any other 
US territory, or anywhere else other than the 50 states 
and  Washington,  DC).  We  defined  exercise  as  vigorous 
activity (≥20 min on ≥3 d/wk), some activity, or no activity 
(18).
We categorized respondents into smokers and nonsmokers. 
Smokers were defined as respondents who reported smok-
ing at least 100 cigarettes in their life and answered “every 
day” or “some days” to the question, “Do you now smoke 
cigarettes?”  Nonsmokers  answered  no  to  the  question, 
“Have you smoked ≥100 cigarettes in your entire life?” or 
to the question “Do you now smoke cigarettes?” We defined 
alcohol use as heavy (≥2 drinks/d for men, ≥1 drink/d for 
women), moderate (<2 drinks/d but >12 drinks/y for men, 
<1  drink/d  but  >12  drinks/y  for  women),  and  low/none 
(those who had never had a drink or <12 drinks/y).
To account for differential selection probabilities and sur-
vey  nonresponse  we  weighted  participant  data;  weights 
were poststratified to reflect population totals. We further 
adjusted weights for item nonresponse on adiposity indica-
tors and CVD outcomes based on age group, race/ethnic-
ity, and sex. We conducted statistical analysis using SAS 
version 9.0 (SAS Institute, Inc, Cary, North Carolina) and 
used SUDAAN version 10.0 (RTI International, Research 
Triangle Park, North Carolina) to obtain standard error 
estimates  and  95%  confidence  intervals  (CIs)  by  Taylor 
series linearization. We age-adjusted New York City and 
national  prevalence  estimates  to  the  2000  US  standard 
population aged 20 years or older (19). Significance was 
defined as P < .05. We calculated relative standard errors 
for all means and percentages; estimates with relative stan-
dard errors of more than 30% are considered unreliable. To 
test differences between NYC HANES and NHANES sur-
vey estimates, we used a linear contrast t test.
To  assess  associations  between  each  adiposity  measure 
and the hypertension and hypercholesterolemia outcomes 
we used logistic regression. For association between each 
adiposity measure and a 3-level indicator of glucose metab-
olism (diabetes, IFG, and normal glucose metabolism), we 
used  multinomial  regression.  Base  models  included  the 
CVD  risk  factor  as  the  dependent  variable  and  known 
confounders (age, sex, race/ethnicity, education, income, 
nativity, exercise, smoking, and alcohol use) as the inde-
pendent variables. We included each adiposity measure in 
a separate base model for each of 3 CVD outcomes. Models 
were also stratified by race/ethnicity.
Results
NYC HANES versus NHANES
The  overall  age-adjusted  prevalence  of  obesity  among 
New York City adults (26%) was significantly lower than 
the national prevalence (31%) (Table 1). The prevalence 
of obesity among New York City middle-aged adults (P = 
.02) and adults who were young, men, white, black, had 
at least a high school education, or had an annual house-
hold income of at least $20,000 (P < .01) was significantly 
lower than that of their national counterparts. The overall 
prevalence  of  elevated  waist  circumference  among  New 
York City adults was 46%, also significantly lower than 
the national prevalence of 52% (P < .01).
The  prevalence  of  elevated  waist-to-height  ratio  was 
significantly  higher  among  New  York  City  adults  than 
among US adults (82% vs 79%, P = .03). Specifically, the 
prevalence  was  significantly  higher  among  New  York 
City adults aged 60 or older, women, those with at least 
a high school education, or those with an annual house-
hold income of less than $20,000 compared with adults 
nationwide  (P  <  .05).  Direct  comparisons  between  New 
York City’s Hispanic population and that from NHANES 
are  not  possible  because  of  differing  regions  of  origin. 
However,  both  groups  had  a  similarly  high  prevalence 
of elevated waist-to-height ratio (90% for New York City 
Hispanics vs 89% for US Mexican Americans and 83% for 
other US Hispanics).
Excess adiposity and CVD risk
Diabetes and IFG
After adjusting for covariates, we found that people with 
excess  adiposity  for  any  measure  had  approximately  3 
times the odds of having diabetes as those with normal 
adiposity (Table 2). Overall, obese participants and those 
with elevated waist-to-height ratio were twice as likely to 
have IFG. Among whites, both obesity and elevated waist 
circumference had large associations with diabetes (Table 
3); however, estimates had wide CIs. Among Hispanics, VOLUME 8: NO. 3
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obesity was associated with diabetes and among whites it 
was associated with IFG. Elevated waist-to-height ratio 
was significantly associated with IFG among Hispanics; 
however, CIs were wide.
Hypertension
Overall, obese participants and those with elevated waist-
to-height ratio had more than 2.5 times the odds of hav-
ing hypertension as either nonobese participants or those 
with normal waist-to-height ratios. We found a smaller 
but  significant  association  among  those  with  elevated 
waist  circumference.  We  found  significant  associations 
for obesity and hypertension for all racial/ethnic groups. 
Elevated waist-to-height ratio was significantly associated 
with hypertension among whites and Hispanics; however, 
CIs were wide.
Hypercholesterolemia
All  adiposity  measures  had  similar  associations  with 
hypercholesterolemia  after  adjusting  for  covariates. 
Participants with elevated adiposity were about twice as 
likely to have hypercholesterolemia as those with normal 
measures. Whites had significantly higher odds of hyper-
cholesterolemia  for  obesity,  elevated  waist  circumfer-
ence, and elevated waist-to-height ratio. Hispanics with 
elevated waist-to-height ratio were at significantly higher 
risk for hypercholesterolemia, but the CI was wide. Among 
Asians, obesity was significantly associated with hyper-
cholesterolemia.
Discussion
We observed a lower prevalence of obesity and elevated 
waist circumference in New York City than nationally but 
a higher prevalence of elevated waist-to-height ratio. In the 
New York City adult population, most measures of excess 
adiposity were significantly associated with increased odds 
of diabetes, IFG, hypertension, and hypercholesterolemia. 
No single adiposity indicator was consistently associated 
with the CVD risk factors across all racial/ethnic groups, 
but obesity was consistently associated with hypertension 
across all racial/ethnic groups. 
The lower prevalence of obesity in New York City com-
pared with the United States is notable, given that New 
York  City  has  a  larger  proportion  of  blacks,  Hispanics, 
and people of low socioeconomic status (20,21), groups that   
typically have a higher prevalence of obesity (22). Our study 
confirms higher obesity prevalence in blacks, Hispanics, 
and people of lower socioeconomic status compared with 
others in New York City, but we found that the prevalence 
of obesity and elevated waist circumference in New York 
City  subgroups  are  both  lower  than  found  nationally. 
Lower obesity may result from New York City’s urban set-
ting; adults in the New York metropolitan area have lower 
rates than other US adults of car use and higher rates of 
active commuting (walking or bicycling to work) (23,24), 
which have been linked to increased physical activity and 
lower prevalence of excess adiposity (25). New York City 
also has a large immigrant population (nearly 40% of the 
New York City adult population is foreign-born), who have 
a lower prevalence of obesity than US-born New Yorkers.
Despite the lower prevalence of obesity and elevated waist 
circumference,  we  found  significantly  higher  prevalence 
of elevated waist-to-height ratio in New York City than 
in the United States. This finding may be the result of 
the  large  New  York  City  Hispanic  population  and  its 
substantially higher waist-to-height ratios. Higher waist-
to-height values among Hispanics have been documented 
in  at  least  1  other  study,  which  showed  that  Mexicans 
residing in Mexico City, Mexican Americans residing in 
San  Antonio,  Texas,  and  white  residents  from  Spanish 
towns had higher mean waist-to-height ratios compared 
with non-Hispanic whites in San Antonio (26). However, 
little  is  known  about  waist-to-height  ratio  in  Hispanic 
groups  other  than  Mexicans.  New  York  City  Hispanics 
are primarily of Puerto Rican and Dominican descent (20), 
and, based on these findings, appear to also have higher 
waist-to-height ratio than other racial/ethnic groups.
Several studies (4-6) support our results that most adipos-
ity measures were significantly associated with increased 
odds of diabetes, IFG, hypertension, and hypercholester-
olemia. However, in race/ethnicity-specific analyses, these 
results were less consistent. Obesity was associated with 
hypertension across all racial/ethnic groups, but obesity 
and other adiposity indicators were not consistently asso-
ciated with other CVD outcomes (eg, among whites and 
Hispanics, elevated waist-to-height ratio was associated 
with  both  hypertension  and  hypercholesterolemia,  but 
among blacks it was associated with diabetes). 
Previous  findings  have  demonstrated  that  associations 
between  adiposity  measures  and  CVD  risk  differ  by 
race/ethnicity. Okosun et al found that excess abdominal 
adiposity (as measured by elevated waist circumference) VOLUME 8: NO. 3
MAY 2011
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was associated with an increased risk of prehypertension, 
hypertension, and multiple metabolic syndrome (defined 
as 2 or more of the following: hypertension, diabetes, dys-
lipidemia, hyperinsulinemia, or hypertriglyceridemia) in 
whites, blacks, and Hispanics; the associations often were 
strongest for blacks and Hispanics (27-29). Furthermore, 
Ghandehari et al found that both BMI and waist circum-
ference were associated with mean levels of fasting glu-
cose, blood pressure, and cholesterol among whites, blacks, 
and Hispanics; however, this relationship was attenuated 
among blacks compared with other racial/ethnic groups 
(30).  In  this  study,  obesity  was  consistently  associated 
with hypertension across the racial/ethnic groups, but we 
did not find consistent associations of elevated waist cir-
cumference and obesity with all of the examined CVD risk 
factors. Differing findings may be due to the small sample 
size in our analysis, thereby limiting statistical power to 
observe significant associations.
Our analyses are based on the use of accepted or proposed 
cutoff values for each adiposity indicator. Other studies 
have  assessed  adiposity  indicators  as  linear  predictors 
or quartiles of linear predictors or have identified cutoffs 
based on receiver operating curves (6,31,32). For example, 
Janssen and coauthors concluded that waist circumference 
was a better predictor of health endpoints than was BMI 
when waist circumference was evaluated as a continuous 
variable (33). Our objective was not to identify optimal val-
ues for predicting CVD risk factors, but we recognize that 
the explanatory power of the adiposity indicators is limited 
by the predefined cutoff values used. Furthermore, because 
considerations such as ease of use, interpretability, cost, 
and feasibility are important criteria for acceptability (34), 
we thought that an assessment based on accepted cutoffs 
would offer the most practical application.
An additional limitation is the small sample sizes used in 
some subgroup assessments, which resulted in large CIs, 
reducing power to assess significant differences in asso-
ciations. Furthermore, NYC HANES is a cross-sectional 
survey, and causal inferences regarding the observed asso-
ciations cannot be made. Finally, data are subject to poten-
tial sources of error, including recall bias for self-reported 
information and measurement error in the examination 
components.  However,  standardized  quality  assurance 
procedures from NHANES protocols were in place to limit 
measurement error.
In summary, the prevalence of excess adiposity as mea-
sured by obesity and elevated waist circumference in New 
York City was lower than national rates. New York City 
had  higher  prevalence  of  elevated  waist-to-height  ratio 
compared with the United States, likely because of New 
York City’s large Hispanic population. Furthermore, our 
results show that in the general population, all 3 measures 
of excess adiposity were significantly associated with CVD 
risk factors; however, race/ethnicity-specific results were 
less  consistent.  Further  investigation  into  the  optimal 
adiposity measure to predict CVD risk across racial/ethnic 
populations may be warranted.
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Tables
Table 1. Prevalence of Indicators of Excess Adiposity, by Selected Demographic Characteristics, NYC HANES, 2004, and NHANES, 
2003-2004
Characteristic
NYC HANES NHANES
na
Obese,b % (95% 
CI)
Elevated WC,b % 
(95% CI)
Elevated WHR,b 
% (95% CI) na
Obese,b % (95% 
CI)
Elevated WC,b % 
(95% CI)
Elevated WHR,b 
% (95% CI)
Total 1,912 25. (23.1-28.3) .2 (3.5-8.9) 81.9 (9.9-83.) ,05 31.2 (28.5-33.9)c 51.9 (9.-5.5)c 8.8 (.5-80.9)c
Age, yd
20-39 938 20.2 (1.2-23.) 31.5 (2.9-35.3) 0.2 (.-3.) 1,38 2.8 (2.5-31.)c 3.8 (3.3-1.3)c 5. (2.2-8.9)
0-59 2 29.5 (25.9-33.5) 52.8 (8.8-5.8) 8.9 (81.8-8.) 1,21 35.9 (32.0-39.9)c 5.8 (5.5-1.0)c 8. (81.0-8.8)
≥60 2 28. (23.0-3.8) 0.8 (5.-.) 9.9 (9.1-98.) 1, 29. (2.5-32.) .8 (2.8-0.) 91.8 (89.-93.8)c
Sex
Male 809 22.1 (19.0-25.) 25.9 (22.-29.5) 8.0 (.-80.9) 2,059 30.0 (2.0-33.1)c 2. (39.9-.9)c 80.5 (8.0-82.9)
Female 1,103 28.8 (25.-32.) 3. (0.1-.2) 85.1 (83.0-8.0) 2,01 32.3 (28.-3.1) 1.0 (5.1-.8) .2 (3.-80.3)c
Race/ethnicity
Non-Hispanic 
white
58 21.9 (18.2-2.0) 2.8 (38.-.3) 9.8 (.5-82.8) 2,159 29.8 (2.0-32.8)c 51. (8.0-55.3)c .3 (.2-80.0)
Non-Hispanic 
black
13 32.1 (2.8-38.0) 51. (.0-5.3) 9.3 (5.-82.5) 829 3.9 (39.-8.5)c 5. (5.-0.)c 80.0 (.8-82.8)
Non-Hispanic 
Asian
253 . (.0-10.) 2. (20.1-3.) .1 (.8-9.5) NA NA NA NA
Hispanic 38 32.5 (28.2-3.2) 5. (50.2-59.0) 89.9 (88.0-91.5) NA NA NA NA
Non-Hispanic 
other
2 21.1 (10.3-38.)e 33.9 (1.3-5.)e 9. (.-8.8)e 11 13. (8.5-21.3) 33. (2.3-.) 3.3 (2.3-82.0)
Mexican 
American
NA NA NA NA 81 3. (32.1-1.0) 5.8 (9.3-0.2) 89. (8.1-91.9)
Other Hispanic NA NA NA NA 130 28. (19.3-0.3) 50.8 (2.-58.9) 82.8 (.0-8.)
Education
<High school 50 33.2 (28.5-38.2) 52. (.-5.) 85.8 (82.0-88.9) 2,199 33.5 (31.0-3.2) 5.3 (51.5-5.0) 82. (9.0-85.8)
≥High school 1,35 22. (19.9-25.) 3. (0.-.) 80. (8.2-82.) 1,82 29. (2.0-33.0)c 50.0 (.2-53.8)c .0 (3.3-8.5)c
Annual household income, $
<20,000 1 2.3(23.5-31.) .0 (2.-51.) 8.0 (81.0-8.) 1,29 30. (2.1-3.3) 52.2 (9.2-55.2) .2 (3.-80.)c
≥20,000 1,239 25.2 (22.0-28.) 5. (2.2-9.0) 81.2 (8.9-83.3) 2,89 31.1 (2.9-3.5)c 51.9 (8.8-55.0)c 9.5 (.0-81.9)
Nativity
US-born 851 30.0 (2.1-3.1) 8. (.-52.) 81.2 (8.-83.5) 3,220 32. (29.9-35.) 53. (51.1-5.) 8. (.3-80.9)
Foreign-bornf 1,055 21.9 (18.9-25.1) .0 (0.-.5) 82.5 (9.9-8.8) 85 22.9 (18.8-2.) 1.9 (3.1-.0) 9.0 (5.-82.1)
 
Abbreviations: NYC HANES, New York City Health and Nutrition Examination Survey; NHANES, National Health and Nutrition Examination Survey; CI, confidence 
interval; WC, waist circumference; WHR, waist-to-height ratio; NA, not assessed. 
a Total may not equal the sum of subgroups because of missing data. 
b Obesity defined as ≥30 kg/m2. Elevated waist circumference defined as >102 cm for men, >88 cm for women. Elevated waist-to-height ratio defined as ≥0.5. 
c Significant difference between NYC HANES and NHANES at P < .05. 
d Estimates are not age-adjusted. 
e The relative standard error for this estimate was >30% or the denominator was <50, indicating that it may be unstable and should be interpreted with caution. 
f Participants born in Puerto Rico, US Virgin Islands, any other US territory, or anywhere other than the 50 states and Washington, DC.VOLUME 8: NO. 3
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Table 2. Odds of Associations Between Indicators of Excess Adiposity and Risk Factors for Cardiovascular Disease, NYC HANES, 
2004
Indicatora ORb (95% CI) AORc (95% CI)
Diabetes,d n = 1,253
Obese 3.2 (2.0-5.2) 3.5 (2.0-.3)
Elevated waist circumference 3.0 (1.9-.8) 3.3 (1.8-.0)
Elevated waist-to-height ratio 5.2 (2.-11.) 3.0 (1.2-.2)
Impaired fasting glucose,d n = 1,253
Obese 2.1 (1.5-3.0) 2. (1.-3.5)
Elevated waist circumference 1.3 (1.0-1.9) 1.5 (1.0-2.3)
Elevated waist-to-height ratio 2. (1.-.2) 2.1 (1.3-3.)
Hypertension,e n = 1,811
Obese 2. (1.9-3.0) 2. (1.9-3.)
Elevated waist circumference 2.3 (1.8-3.0) 1.5 (1.1-2.2)
Elevated waist-to-height ratio 5.9 (3.-9.) 2. (1.5-.)
Hypercholesterolemia,f n = 1,646
Obese 1.8 (1.3-2.) 1.9 (1.3-2.)
Elevated waist circumference 2.2 (1.-2.9) 1.9 (1.3-2.9)
Elevated waist-to-height ratio 3.3 (2.2-.8) 2.3 (1.5-3.5)
 
Abbreviations: NYC HANES, New York City Health and Nutrition Examination Survey; OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio. 
a Obesity defined as body mass index ≥30.0 kg/m2 (reference <30 kg/m2). Elevated waist circumference defined as >102 cm for men (reference ≤102 cm) 
and >88 cm for women (reference ≤88 cm). Elevated waist-to-height ratio defined as ≥0.5 (reference <0.5).  
b Not adjusted for covariates in base model. 
c Adjusted for covariates in base model. 
d Results from a multinomial model with 3 levels (diabetes, impaired fasting glucose, normal). Base model accounts for age, sex, race/ethnicity, education, 
income, exercise, and nativity. 
e Base model accounts for age, sex, race/ethnicity, education, income, exercise, nativity, smoking, and alcohol use. 
f Base model accounts for age, sex, race/ethnicity, education, income, exercise, nativity, and smoking.VOLUME 8: NO. 3
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Table 3. Odds of Associations Between Indicators of Excess Adiposity and Risk Factors for Cardiovascular Disease, by Race/Ethnicity, 
NYC HANES, 2004
Indicatora
Race/Ethnicity
Non-Hispanic White Non-Hispanic Black Asian Hispanic
n AOR (95% CI) n AOR (95% CI) n AOR (95% CI) n AOR (95% CI)
Diabetesb
Obese 33 1.3 (5.0-59.2) 29 1.1 (0.5-2.) 152 2.3 (0.3-1.1) 59 2. (1.1-5.5)
Elevated waist circumference 33 .3 (2.-22.) 29 1. (0.-.) 152 3. (0.5-25.) 59 2.2 (0.-.)
Elevated waist-to-height ratio 33 3.5 (0.-38.) 29 3.1c (1.0-9.1) NAd NC  0.8 (0.2-2.9)
Impaired fasting glucoseb
Obese 33 5.2 (2.5-10.9) 29 1. (0.-2.) 152 1.5 (0.3-.) 59 1.9 (0.9-3.8)
Elevated waist circumference 33 1.5 (0.-3.1) 29 1.8 (0.-.3) 152 2.2 (0.-.2) 59 1.5 (0.8-2.9)
Elevated waist-to-height ratio 33 1.8 (0.8-.0) 29 3.0 (0.9-9.) NAd NC 59 9.0 (2.-31.)
Hypertensione
Obese 52 2. (1.3-.) 39 2. (1.-.5) 238 3.5 (1.1-11.2) 15 3.2 (1.-5.9)
Elevated waist circumference 52 1.9 (1.0-3.) 39 1. (0.8-3.) 238 1.0 (0.-2.5) 15 1. (0.8-2.5)
Elevated waist-to-height ratio 52 3.1 (1.1-9.0) 39 2.3 (1.0-5.5) 238 1.2 (0.5-3.3) 15 5. (1.-23.)
Hypercholesterolemiaf
Obese 88 2.0 (1.1-3.5) 35 2.1 (1.0-.) 212 5.3 (1.2-23.) 589 1. (0.9-2.9)
Elevated waist circumference 88 2.3 (1.2-.3) 35 2.3 (0.8-.) 212 2.0 (0.9-.8) 589 1. (0.9-2.8)
Elevated waist-to-height ratio 88 2.8 (1.-5.9) 35 1. (0.5-3.) 212 2.0 (0.8-5.2) 589 5. (1.9-1.3)
 
Abbreviations: NYC HANES, New York City Health and Nutrition Examination Survey; AOR, adjusted odds ratio; CI, confidence interval; NA, not applicable; NC, 
not calculated. 
a Obesity defined as body mass index ≥30.0 kg/m2 (reference <30 kg/m2). Elevated waist circumference defined as >102 cm for men (reference ≤102 cm) 
and >88 cm for women (reference ≤88 cm). Elevated waist-to-height ratio defined as ≥0.5 (reference <0.5). 
b Results from a multinomial model with 3 levels (diabetes, impaired fasting glucose, normal). Base model accounts for age, sex, race/ethnicity, education, 
income, exercise, and nativity. 
c Odds are significant at P =.0; the CI includes 1 because of rounding. 
d Value could not be calculated because no Asians with a normal waist-to-height ratio had diabetes or impaired fasting glucose. 
e Base model accounts for age, sex, race/ethnicity, education, income, exercise, nativity, smoking, and alcohol use. 
f Base model accounts for age, sex, race/ethnicity, education, income, exercise, nativity, and smoking.